title: [RACAND syndrome: distinct entity or initial presentation of systemic scleroderma].
authors.forename: Monia
authors.initials: M
authors.lastname: Smiti Khanfir
authors.forename: Syrine
authors.initials: S
authors.lastname: Bellakhal
authors.forename: Fatma
authors.initials: F
authors.lastname: Said
authors.forename: Thouraya
authors.initials: T
authors.lastname: Ben Salem
authors.forename: Imed
authors.initials: I
authors.lastname: Ben Ghorbel
authors.forename: Mounir
authors.initials: M
authors.lastname: Lamloum
authors.forename: Amira
authors.initials: A
authors.lastname: Hamzaoui
authors.forename: Mohamed Habib
authors.initials: MH
authors.lastname: Houman
mesh_terms: D061605:Administration, Intravenous; D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005385:Fingers / Q000473:pathology*; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D009336:Necrosis; D011928:Raynaud Disease / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D012307:Risk Factors; D012595:Scleroderma, Systemic / Q000175:diagnosis; D012720:Severity of Illness Index; D013577:Syndrome; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000974:Antibodies, Antinuclear; D015415:Biomarkers; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; C538950:anticentromere antibody